Synergus

Seminar / webinar: 101 introduction to reimbursement / funding for e-health and diagnostic companies

This webinar gives a basic understanding of the elements relating reimbursement/funding for new innovations in diagnostics / reimbursement that will be crucial to understand before we go participating in the  more specific webinars about specific countries.

In the webinar the following topics will be covered:

• Introduction to funding and reimbursement
  Sometimes there is a misconception that all solutions require implicit reimbursement. In many instances, there will be a way to fund the solution through existing budgets in a way that supports a sustainable business. In other scenarios, a specific reimbursement clearly has to be described.
   
• What are the different categories of how healthcare / drugs /devices are reimbursed?
  This provides a crucial understanding how vastly different the methods of defining reimbursement is and the challenges that arise from this in regard to e-health/diagnostic.
   
• What are the key-mechanism’s for determining reimbursement and how do they function?
  • Diagnosis related groups (DRG’s) based on historical cost data.
  • Drugs and interventions where the clinical and economical is evaluated to determined the use and pricing.

Speaker:

Mattias Kyhlstedt is the CEO and founder of Synergus RWE with an extensive experience of developing market access strategies for new therapies in Europe.